77.58  0.71 (0.92%)		01-30 15:50
Open: 76.71 High: 77.62 Volume: 1,020,061		Pre. Close: 76.87 Low: 76.255 Market Cap: 36,442(M)

Short term
Mid term
Targets	6-month :	93.46	1-year :	109.16
Resists	First :	80.01	Second :	93.46
Pivot price	76.78
Supports	First :	76.18	Second :	73.81
MAs	MA(5) :	76.47	MA(20) :	76.61
	MA(100) :	74.57	MA(250) :	69.43
MACD	MACD :	-0.3	Signal :	-0.4
%K %D	K(14,3) :	56	D(3) :	50
RSI	RSI(14): 51.5
52-week	High :	81.88	Low :	58.72

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ VTR ] has closed below upper band by 34.4%. Bollinger Bands are 26.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	77.33 - 77.8	77.8 - 78.25
Low:	74.74 - 75.29	75.29 - 75.81
Close:	76.02 - 76.84	76.84 - 77.62

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Thu, 29 Jan 2026
Wealth Enhancement Advisory Services LLC Increases Stake in Ventas, Inc. $VTR - MarketBeat

Thu, 29 Jan 2026
Ventas (VTR) to Release Earnings on Thursday - MarketBeat

Tue, 27 Jan 2026
Assessing Ventas (VTR) Valuation As Earnings Growth And Cash Flow Support An Upward Share Price Trend - simplywall.st

Tue, 27 Jan 2026
Chilton Capital Management LLC Raises Stake in Ventas, Inc. $VTR - MarketBeat

Mon, 26 Jan 2026
Does Ventas’ EPS Surge And Uptrend Signal A Stronger Long-Term Thesis For VTR? - Sahm

Mon, 26 Jan 2026
Ventas, Inc. $VTR Holdings Lifted by Lbp Am Sa - MarketBeat

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Real Estate
Industry: REIT - Healthcare Facilities
Shares Out	470 (M)
Shares Float	468 (M)
Held by Insiders	0.5 (%)
Held by Institutions	100.3 (%)
Shares Short	15,870 (K)
Shares Short P.Month	14,670 (K)

EPS	0.52
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	26.32
Profit Margin	4.2 %
Operating Margin	15.5 %
Return on Assets (ttm)	2.1 %
Return on Equity (ttm)	2.1 %
Qtrly Rev. Growth	21.7 %
Gross Profit (p.s.)	4.93
Sales Per Share	11.79
EBITDA (p.s.)	4.49
Qtrly Earnings Growth	201.6 %
Operating Cash Flow	1,550 (M)
Levered Free Cash Flow	1,070 (M)

PE Ratio	145.95
PEG Ratio	0
Price to Book value	2.93
Price to Sales	6.55
Price to Cash Flow	23.44

Dividend	0.47
Forward Dividend	0
Dividend Yield	0.6%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.